Mutations of RAS/RAF Proto-oncogenes Impair Survival After Cytoreductive Surgery and HIPEC for Peritoneal Metastasis of Colorectal Origin
Conclusion:
RAS/RAF mutations impair survival after CRS/HIPEC. The novel BIOSCOPE score reflects tumor biology, adequately stratifies long-term outcomes, and improves patient assessment and selection.
Source: Annals of Surgery - Category: Surgery Tags: ESA Papers Source Type: research
More News: Biology | Cancer | Cancer & Oncology | Chemotherapy | Colorectal Cancer | Peritoneal Cancer